"New York Oncology Hematology (NYOH) is the leading provider of community-based cancer care and blood disorder services. With six convenient locations in Albany, Amsterdam, Clifton Park in Saratoga County, Hudson, and Troy, our team of 35 physicians and more than 350 cancer care specialists see more than 100,000 cancer visits a year."

During the past decade, New York Oncology Hematology PC - Albany Medical Center conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 34 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 19 clinical trials were completed. i.e. 316.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New York Oncology Hematology PC - Albany Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Oncology Hematology PC - Albany Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "New York Oncology Hematology PC - Albany Medical Center" are "Breast Cancer" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Recurrent Melanoma" (4 trials) and "Stage IIIB Cutaneous Melanoma AJCC v7" (3 trials). Many other conditions were trialed in "New York Oncology Hematology PC - Albany Medical Center" in a lesser frequency.

Most popular intervention types in "New York Oncology Hematology PC - Albany Medical Center" are "Drug" (41 trials), "Other" (27 trials), "Biological" (22 trials), "Radiation" (8 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Quality-of-Life Assessment" (11 trials), "Docetaxel" (8 trials), "Bevacizumab" (7 trials) and "Ipilimumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "New York Oncology Hematology PC - Albany Medical Center" are 37 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "New York Oncology Hematology PC - Albany Medical Center". undefined are not yet recruiting, 2 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in New York Oncology Hematology PC - Albany Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in New York Oncology Hematology PC - Albany Medical Center, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".